Jacobs Levy Equity Management’s ContraFect Corporation CFRX Stock Holding History

Jacobs Levy Equity Management’s Portfolio CFRX Stock Details CFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-785	Closed	-$301K	–	1175
2021 Q1	$301K	Buy	+785	New	+$339K	﹤0.01%	929
2019 Q1	–	Sell	-21	Closed	-$25K	–	1087
2018 Q4	$25K	Buy	+21	New	+$33.3K	﹤0.01%	960

Other funds holding CFRX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Jacobs Levy Equity Management's CFRX Position: Q2 2021 in Review

Jacobs Levy Equity Management sold out of ContraFect Corporation (CFRX) in Q2 2021, closing a stake of 785 shares — an estimated $301K sold.

Jacobs Levy Equity Management first reported a position in CFRX in Q4 2018 and held it in 2 quarters. The position peaked at $301K in Q1 2021. 66 funds tracked by Wall St. Rank hold CFRX as of Q2 2021.

Jacobs Levy Equity Management reported no remaining ContraFect Corporation position as of Q2 2021 after selling out during the quarter.
Jacobs Levy Equity Management sold 785 ContraFect Corporation shares in Q2 2021, an estimated $301K.
Jacobs Levy Equity Management first reported a position in ContraFect Corporation in Q4 2018 and held it in 2 quarters.
Jacobs Levy Equity Management's ContraFect Corporation position peaked at $301K in Q1 2021.
66 funds tracked by Wall St. Rank held ContraFect Corporation as of Q2 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.